ROBERT ROSEMUND: Open Payments
NPI 1700854890 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 38 payments from 14 companies in 2025. Trend: 2023 $912 · 2024 $812 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $162 |
| Abbott Laboratories | 7 | $146 |
| PFIZER INC. | 6 | $108 |
| Astellas Pharma US Inc | 4 | $83 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| COLOPLAST CORP | 1 | $37 |
| Tactile Systems Technology Inc | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
Products named: FREESTYLE LIBRE 3, Ozempic, Veozah, PREVNAR 20, Wegovy, ELIQUIS, SHINGRIX, Titan.
Industry payments across FL — which companies pay providers there.
